Ciuca Lavinia, Pepe Paola, Bosco Antonio, Caccio Simone Mario, Maurelli Maria Paola, Sannella Anna Rosa, Vismarra Alice, Cringoli Giuseppe, Kramer Laura, Rinaldi Laura, Genchi Marco
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy.
European Union Reference Laboratory for Parasites, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Front Vet Sci. 2021 Mar 26;8:626424. doi: 10.3389/fvets.2021.626424. eCollection 2021.
A field trial performed in-home conditions was conducted on 24 dogs naturally infected with , in order to compare the efficacy of fenbendazole and metronidazole. Animals were allocated in groups randomly in order to obtain two groups of 12 dogs each with similar parasitic loads of cysts: dogs in Group A were treated with fenbendazole (Panacur®, Intervet Italia Srl) administered at the dose of 50 mg/kg orally once a day for 5 consecutive days, dogs in Group B were treated with metronidazole (Flagyl®, Zambon Italia Srl) administered orally at the dose of 50 mg/kg, once a day for 5 consecutive days. All the dogs that were shedding cysts after the first treatment (Day 0) were retreated (either at Day 7 or at Day 14 or at Day 21) until a negative result was obtained with the same treatment. Additionally, all the dogs were re-examined at Day 50. All the dogs were tested for the presence of cysts using a fecal flotation method (FLOTAC). The percent efficacy of the treatments (A and B) was calculated at each sampling point (Days 7, 14, 21, and 50) as reduction in mean cysts. After the first therapy, on day 7, 4/12 (33.3%) dogs tested positive for cysts in the Group A and 5/12 (41.7%) in the Group B. Efficacies at (Days 7, 14, 21, and 50) of the treatments against infection were 80.9, 94, 100, and 97% in the Group A and 70.8, 99, 100, and 97.1% in the Group B. Statistically significant differences were not observed between the efficacy of Fenbendazole and Metronidazole against infection by ( = 0.686). Molecular analysis revealed full homology (i.e., 100% with JN416550) with the canine specific assemblage D in six positive dogs. Different hypotheses might explain the re-appearance of the cysts in some dogs after treatment, e.g., re-infection from the home environment, the correct medication given by the owners, the diet, as well as treatment failure, but also biological issues related to the intermittent excretion of cysts.
在家庭环境中对24只自然感染[寄生虫名称未给出]的犬进行了一项田间试验,以比较芬苯达唑和甲硝唑的疗效。将动物随机分组,以获得两组各12只犬,其[寄生虫名称未给出]囊肿的寄生负荷相似:A组犬用芬苯达唑(Panacur®,意大利英特威有限公司)以50mg/kg的剂量口服,每天一次,连续5天;B组犬用甲硝唑(Flagyl®,意大利赞邦有限公司)以50mg/kg的剂量口服,每天一次,连续5天。所有在首次治疗(第0天)后排出[寄生虫名称未给出]囊肿的犬均进行再次治疗(在第7天、第14天或第21天),直到用相同治疗方法获得阴性结果。此外,所有犬在第50天重新检查。所有犬均使用粪便漂浮法(FLOTAC)检测[寄生虫名称未给出]囊肿的存在。在每个采样点(第7天、第14天、第21天和第50天)计算治疗组(A组和B组)的疗效百分比,以平均[寄生虫名称未给出]囊肿减少量表示。首次治疗后,在第7天,A组12只犬中有4只(33.3%)[寄生虫名称未给出]囊肿检测呈阳性,B组12只犬中有5只(41.7%)呈阳性。治疗组在第7天、第14天、第21天和第50天对[寄生虫名称未给出]感染的疗效分别为A组80.9%、94%、100%和97%,B组70.8%、99%、100%和97.1%。在芬苯达唑和甲硝唑对[寄生虫名称未给出]感染的疗效之间未观察到统计学上的显著差异(P = 0.686)。分子分析显示,在6只阳性犬中与犬特异性组合D完全同源(即与JN416550的同源性为100%)。不同的假设可能解释了一些犬在治疗后[寄生虫名称未给出]囊肿再次出现的原因,例如来自家庭环境的再次感染、主人给予的正确药物、饮食以及治疗失败,还有与[寄生虫名称未给出]囊肿间歇性排泄相关的生物学问题。